- Home
- NEGG vs SIGA Comparison
NEGG vs SIGA Comparison
Compare NEGG & SIGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NEGG | SIGA |
|---|---|---|
| Founded | 2001 | 1995 |
| Country | United States | United States |
| Employees | 714 | N/A |
| Industry | Other Specialty Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 341.9M | 309.8M |
| IPO Year | N/A | 2016 |
Fundamental Metrics
Financial Performance| Metric | NEGG | SIGA |
|---|---|---|
| Price | $14.85 | $3.88 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 54.7K | ★ 547.4K |
| Earning Date | 04-28-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 13.24% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $224.81 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $14.54 | $3.56 |
| 52 Week High | $137.84 | $9.62 |
Technical Indicators
Market Signals| Indicator | NEGG | SIGA |
|---|---|---|
| Relative Strength Index (RSI) | 29.13 | 36.45 |
| Support Level | N/A | N/A |
| Resistance Level | $21.95 | $4.84 |
| Average True Range (ATR) | 1.20 | 0.16 |
| MACD | 0.23 | -0.05 |
| Stochastic Oscillator | 6.62 | 35.50 |
Price Performance
Historical ComparisonAbout NEGG Newegg Commerce Inc.
Newegg Commerce Inc is an e-commerce company offering direct sales and an online marketplace platform for IT computer components, consumer electronics, entertainment, smart home, and gaming products, and provides certain third-party logistics services globally. Geographically, it operates in the United States, Canada, and the Rest of the world.
About SIGA SIGA Technologies Inc.
SIGA Technologies Inc a commercial-stage pharmaceutical company. The Company sells its product, TPOX oral TPOXX, also known as tecovirimat, Tecovirimat-SIGA, or TEPOXX (tecovirimat) in certain international markets, to the U.S. Government and international governments (including government-affiliated entities). The Company operates in one single operating and reportable segment, which includes all activities related to the sale of the Company's Oral and IV TPOXX as well as research and development services.